Metformin added to insulin therapy in poorly controlled type 2 diabetes

被引：16
|
作者：
Hirsch, IB [1 ]
机构：
[1] Univ Washington, Med Ctr, Sch Med, Dept Med,Div Metab Endocrinol & Nutr, Seattle, WA 98195 USA
来源：
DIABETES CARE | 1999年 / 22卷 / 05期
关键词：
D O I：
10.2337/diacare.22.5.854b
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：854 / 854
页数：1
相关论文
共 50 条
  • [21] Predictors of response to insulin therapy in youth with poorly-controlled type 2 diabetes in the TODAY trial
    Bacha, Fida
    El Ghormli, Laure
    Arslanian, Silva
    Zeitler, Philip
    Laffel, Lori M.
    Katz, Lorraine E. Levitt
    Gandica, Rachelle
    Chang, Nancy T.
    Sprague, Jennifer E.
    Macleish, Sarah A.
    PEDIATRIC DIABETES, 2019, 20 (07) : 871 - 879
  • [22] Dapagliflozin Plus Saxagliptin Add-on Therapy Compared With Insulin in Patients With Type 2 Diabetes Poorly Controlled by Metformin With or Without Sulfonylurea Therapy: A Randomized Clinical Trial
    Vilsboll, Tina
    Ekholm, Ella
    Johnsson, Eva
    Dronamraju, Nalina
    Jabbour, Serge
    Lind, Marcus
    DIABETES CARE, 2019, 42 (08) : 1464 - 1472
  • [23] Empagliflozin added to metformin and sulfonylurea therapy in patients with sub-optimally controlled type 2 diabetes mellitus
    Lewin, Andrew J.
    Frias, Juan P.
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (05) : 781 - 784
  • [24] Sustained efficacy of dapagliflozin when added to metformin in type 2 diabetes inadequately controlled by metformin monotherapy
    Bailey, C. J.
    Gross, J. L.
    Yadav, M.
    Iqbal, N.
    Mansfield, T. A.
    List, J. F.
    DIABETOLOGIA, 2011, 54 : S67 - S67
  • [25] Impact of Canagliflozin Added on to Insulin and Metformin in Type 2 Diabetes: A Substudy of the CANVAS Trial
    Rosenstock, Julio
    Matthews, David
    Desai, Mehul
    Capuano, George
    Meininger, Gary
    Canovatchel, William
    DIABETES, 2015, 64 : A335 - A336
  • [26] Efficacy and safety of alogliptin added to metformin therapy in patients with type 2 diabetes
    Nauck, Michael
    Ellis, Graham
    Fleck, Penny
    Wilson, Craig
    Mekki, Qais
    DIABETES, 2008, 57 : A142 - A143
  • [27] Efficacy and safety of sitagliptin added to ongoing metformin therapy in type 2 diabetes patients who were inadequately controlled on metformin alone
    Meininger, G.
    Charbonnel, B.
    Karasik, A.
    Liu, J.
    Wu, M.
    Meehan, A.
    DIABETOLOGIA, 2006, 49 : 5 - 6
  • [28] Effect of Sitagliptin Added On to Insulin Glargine and Metformin in Obese Subjects with Diabetes Type 2
    Zivkovic, Teodora Beljic
    Petkovic, Milica Marjanovic
    Soldatovic, Ivan
    Kanlic, Dobrila
    Vuksanovic, Miljanka
    Topalov, Drina
    DIABETES, 2014, 63 : A598 - A598
  • [29] Efficacy and safety of gemigliptin compared with sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone
    Rhee, E. J.
    Min, K. W.
    Jang, H. C.
    Chung, C. H.
    Nam-Goong, I. S.
    Bae, H. Y.
    Lee, M. K.
    Baik, S. H.
    Shivane, V. K.
    Sosale, A. R.
    Dharmalingam, M.
    Gandhi, P.
    Gupta, S. K.
    Kim, J. A.
    Kim, S. W.
    DIABETOLOGIA, 2012, 55 : S352 - S352
  • [30] Efficacy and Safety of Gemigliptin Compared With Sitagliptin Added to Ongoing Metformin Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Alone
    Rhee, Eun Jung
    Min, Kyung Wan
    Jang, Hak Chul
    Nam-Goong, Il Seong
    Chung, Choon Hee
    Park, Joong Yeol
    Bae, Hak Yeon
    Kim, Doo-Man
    Baik, Sei Hyun
    Lee, Moon-Kyu
    Kim, Byung-Joon
    Chang, Sang Ah
    Ahn, Chul Woo
    Kim, Yong Seong
    Yoon, Kun Ho
    Park, Kyong Soo
    Kim, Hae Jin
    Shivane, Vyankatesh K.
    Sosale, Aravind R.
    Dharmalingam, Mala
    Gandhi, Pramod
    Gupta, Sandeep Kumar
    Pitale, Shailesh
    Agarwal, Pankaj Kumar
    Rais, Nadeem
    Mohan, V.
    Mahesh, Uma
    Kim, Jeong Ae
    Kim, Pan Kyung
    Kim, Sun Woo
    DIABETES, 2012, 61 : A291 - A291
12345